Liquid biopsy (LB) is a minimally invasive method which aims to detect circulating tumor-
derived components in body fluids. It provides an alternative to current cancer screening …

Breast cancer management has witnessed significant advancements, especially in the
diagnosis and treatment response monitoring through the implementation of imaging …

Importance Liquid biopsy is an emerging tool with the potential to change oncologic care
practices. Optimal clinical applications for its use are currently undefined for surgical …

Liquid biopsies refer to the isolation and analysis of tumor-derived biological material from
body fluids, most commonly blood, in order to provide clinically valuable information for the …

Simple Summary Early-stage disease non-small cell lung cancer has better outcomes than
advanced disease, but 5-year survival rates can drop to approximately 50% in cases of …

CXCR4, JUNB and PD-L1 are implicated in cancer progression and metastasis. The current
study investigated these biomarkers in CTCs isolated from metastatic prostate cancer …

Liver cancer (hepatocellular carcinoma [HCC]) is a fatal cancer worldwide and often is
detected at an advanced stage when treatment options are very limited. This drives the …

In recent years, cancerous cases have increased remarkably worldwide, and metastasis is
the leading cause of death. Therefore, research on the early detection of cancer and …

Liquid biopsy, an innovative method for early diagnosis of cancer, has changed the
traditional method of diagnosing lung cancer and is considered a feasible auxiliary …

Given the low specificity of the routinely used biomarker prostate-specific antigen, circulating
tumor cell (CTC) enumeration seems to be particularly useful in the monitoring of prostate …